News and Press Releases
10/14/2014
Ebola Cases Bring Practical and Clinical Challenges
Caring for the first two Ebola virus–infected humanitarian workers in the United States required high-level clinical services for the patients as well as practical strategies to deal with fears among hospital staff and the local community. For hospital staff, twice-daily "town hall" meetings were10/14/2014 Press Release
Pediatric Pharmacotherapy Self Assessment Book Now Available from ASHP
ASHP has published Pediatric Pharmacotherapy Self Assessment, authored by Sandra Benavides, Pharm.D.; Hanna Phan, Pharm.D., BCPS; and Milap C. Nahata, Pharm.D., M.S., to help pharmacists evaluate and improve their care of pediatric patients. With little clinical data available on the efficacy10/14/2014 Press Release
ASHP Publishes New Edition of Popular Handbook on Injectable Drugs
ASHP has released the 18th edition of its newly updated Handbook on Injectable Drugs™. With its 38-year track record, the Handbook is considered the “Gold Standard” for translating thorough, complex data on parenteral drugs into an essential resource that is easily accessible to busy practitioners w10/1/2014
Medicare's Inpatient PPS Continues Focus on Quality, Value
With the start of a new federal fiscal year today, Medicare has underway three programs that can alter payments to an acute care hospital on the basis of past performance on measures of patient care, safety, and outcomes. The three programs, part of the Medicare hospital inpatient prospective paym10/1/2014
ASHP Asks Genentech to Reconsider Distribution Change, Calls for Stakeholder Meeting
A planned change to the distribution system for bevacizumab, trastuzumab, and rituximab could adversely impact patient care, ASHP CEO Paul W. Abramowitz told Genentech CEO Ian T. Clark today. ASHP noted that the current supply chain effectively addresses patient care needs while providing for fina9/19/2014
Dulaglutide Approved for Type 2 Diabetes
The glucagon-like peptide (GLP)-1 receptor agonist dulaglutide has been approved for the treatment of type 2 diabetes, FDA and Eli Lilly and Company announced September 18. Dulaglutide will be available later this year under the brand name Trulicity, Lilly stated. According to the labeling (PD9/19/2014
Students Take to Capitol Hill for Provider Status
Fifteen pharmacy students answered ASHP's call to spend September 17 on Capitol Hill as part of a group advocating to grant pharmacists status as healthcare providers in the Medicare program. In all, 108 ASHP members visited 146 congressional offices during ASHP's annual Legislative Day. This yea9/18/2014